Among the 286 IDC patients, we got 26 cases of triple-negative breast cancer (TNBC) patients; we correlated PRSS3 protein expression with TNBC patents’ clinical characteristics (Table 3). Here, PRSS3 is linked to triple-negative breast carcinoma.